Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
Aba Anoa ScottJoel YarneyVerna VanderpuyeCharles Akoto AidooMervin AgyemanSamuel Ntiamoah BoatengEvans SasuKwabena AnarfiTony Obeng-MensahPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
There was no difference between LDR and HDR brachytherapy in local control and disease-free survival for all stages of disease, except in stage IIIB. These findings highlight the need to refine this brachytherapy technique for this group of patients.